Company Vivos Therapeutics, Inc.
Equities
VVOS
US92859E2072
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.45 USD | +6.52% | +17.22% | -80.31% |
May. 14 | Transcript : Vivos Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Vivos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 119
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Oral Appliances and Therapeutic Treatments
100.0
%
| 16 | 100.0 % | 14 | 100.0 % | -13.87% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 16 | 100.0 % | 14 | 100.0 % | -13.87% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Todd Huntsman
FOU | Founder | - | 16-07-06 |
RaeAnn Byrnes
FOU | Founder | - | 16-07-06 |
Susan McCullough
FOU | Founder | - | 16-07-06 |
R. Huntsman
CEO | Chief Executive Officer | 66 | 16-07-06 |
Bradford Amman
DFI | Director of Finance/CFO | 62 | 18-09-30 |
Neil Kline
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Julie Gannon
IRC | Investor Relations Contact | - | - |
Patrick Kircher
SAM | Sales & Marketing | - | - |
- | - | ||
Nick DeGennaro
PRN | Corporate Officer/Principal | - | 19-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Leonard Sokolow
BRD | Director/Board Member | 67 | 20-05-31 |
Mark Lindsay
BRD | Director/Board Member | 61 | 20-05-31 |
Anja Krammer
BRD | Director/Board Member | 56 | 20-05-31 |
Ralph Green
BRD | Director/Board Member | 84 | 20-05-31 |
R. Huntsman
CEO | Chief Executive Officer | 66 | 16-07-06 |
Matthew Thompson
BRD | Director/Board Member | 62 | 20-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,227,270 | 3,025,421 ( 93.75 %) | 0 | 93.75 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-80.31% | 7.91M | |
-24.88% | 7.32B | |
+7.04% | 6.66B | |
+15.10% | 5.5B | |
-15.87% | 4.88B | |
+14.96% | 4.1B | |
-21.75% | 3.89B | |
-25.03% | 2.83B | |
+44.01% | 2.31B | |
+1.98% | 2.07B |
- Stock Market
- Equities
- VVOS Stock
- Company Vivos Therapeutics, Inc.